1. Home
  2. NTCT vs VCEL Comparison

NTCT vs VCEL Comparison

Compare NTCT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • VCEL
  • Stock Information
  • Founded
  • NTCT 1984
  • VCEL 1989
  • Country
  • NTCT United States
  • VCEL United States
  • Employees
  • NTCT N/A
  • VCEL N/A
  • Industry
  • NTCT EDP Services
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTCT Technology
  • VCEL Health Care
  • Exchange
  • NTCT Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • NTCT 1.9B
  • VCEL 1.8B
  • IPO Year
  • NTCT 1999
  • VCEL 1997
  • Fundamental
  • Price
  • NTCT $26.15
  • VCEL $39.31
  • Analyst Decision
  • NTCT Buy
  • VCEL Strong Buy
  • Analyst Count
  • NTCT 2
  • VCEL 6
  • Target Price
  • NTCT $32.00
  • VCEL $60.40
  • AVG Volume (30 Days)
  • NTCT 577.8K
  • VCEL 642.0K
  • Earning Date
  • NTCT 11-06-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • NTCT N/A
  • VCEL N/A
  • EPS Growth
  • NTCT N/A
  • VCEL 236.54
  • EPS
  • NTCT 1.24
  • VCEL 0.25
  • Revenue
  • NTCT $862,770,000.00
  • VCEL $258,716,999.00
  • Revenue This Year
  • NTCT $5.30
  • VCEL $18.35
  • Revenue Next Year
  • NTCT $2.68
  • VCEL $22.26
  • P/E Ratio
  • NTCT $20.99
  • VCEL $160.49
  • Revenue Growth
  • NTCT 9.60
  • VCEL 14.05
  • 52 Week Low
  • NTCT $18.12
  • VCEL $29.24
  • 52 Week High
  • NTCT $30.67
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 45.05
  • VCEL 58.44
  • Support Level
  • NTCT $26.52
  • VCEL $37.51
  • Resistance Level
  • NTCT $27.62
  • VCEL $41.66
  • Average True Range (ATR)
  • NTCT 1.01
  • VCEL 1.83
  • MACD
  • NTCT -0.34
  • VCEL -0.14
  • Stochastic Oscillator
  • NTCT 15.80
  • VCEL 50.53

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: